MedKoo Cat#: 562355 | Name: UC-112
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

UC-112 is a small-molecule inhibitor that targets the interaction between heat shock protein 90 (Hsp90) and its co-chaperones, disrupting protein folding and stability in cancer cells. By inhibiting Hsp90 activity, UC-112 promotes the degradation of oncogenic client proteins, leading to reduced cell proliferation and increased apoptosis in tumor cells. UC-112 exhibits an IC50 of 0.15 μM against Hsp90 in biochemical assays, indicating its potent inhibitory activity.

Chemical Structure

UC-112
UC-112
CAS#383392-66-3

Theoretical Analysis

MedKoo Cat#: 562355

Name: UC-112

CAS#: 383392-66-3

Chemical Formula: C22H24N2O2

Exact Mass: 348.1838

Molecular Weight: 348.44

Elemental Analysis: C, 75.83; H, 6.94; N, 8.04; O, 9.18

Price and Availability

Size Price Availability Quantity
10mg USD 550.00 2 Weeks
50mg USD 1,350.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
UC-112; UC 112; UC112;
IUPAC/Chemical Name
5-[(Phenylmethoxy)methyl]-7-(1-pyrrolidinylmethyl)-8-quinolinol
InChi Key
LTGLGIQQZXSLLF-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H24N2O2/c25-22-18(14-24-11-4-5-12-24)13-19(20-9-6-10-23-21(20)22)16-26-15-17-7-2-1-3-8-17/h1-3,6-10,13,25H,4-5,11-12,14-16H2
SMILES Code
OC1=C2N=CC=CC2=C(COCC3=CC=CC=C3)C=C1CN4CCCC4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 348.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Bozgeyik I, Ege B, Koparal M, Yumrutas O. Non-coding RNAs transcribed from ultra-conserved regions (T-UCRs) are differentially expressed in dental follicle tissues of impacted mandibular third molars. J Stomatol Oral Maxillofac Surg. 2022 Jun;123(3):271-275. doi: 10.1016/j.jormas.2022.04.015. Epub 2022 Apr 25. PMID: 35477012. 2: das Chagas PF, de Sousa GR, Kodama MH, de Biagi Junior CAO, Yunes JA, Brandalise SR, Calin GA, Tone LG, Scrideli CA, de Oliveira JC. Ultraconserved long non-coding RNA uc.112 is highly expressed in childhood T versus B-cell acute lymphoblastic leukemia. Hematol Transfus Cell Ther. 2021 Jan- Mar;43(1):28-34. doi: 10.1016/j.htct.2019.12.003. Epub 2020 Jan 30. PMID: 32014474; PMCID: PMC7910170. 3: Wang Q, Arnst KE, Xue Y, Lei ZN, Ma D, Chen ZS, Miller DD, Li W. Synthesis and biological evaluation of indole-based UC-112 analogs as potent and selective survivin inhibitors. Eur J Med Chem. 2018 Apr 10;149:211-224. doi: 10.1016/j.ejmech.2018.02.045. Epub 2018 Feb 19. PMID: 29501942; PMCID: PMC5849576. 4: Xiao M, Wang J, Lin Z, Lu Y, Li Z, White SW, Miller DD, Li W. Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties. PLoS One. 2015 Jun 12;10(6):e0129807. doi: 10.1371/journal.pone.0129807. PMID: 26070194; PMCID: PMC4466525. 5: Wang J, Li W. Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors. J Pharmacol Exp Ther. 2014 May;349(2):319-29. doi: 10.1124/jpet.113.212019. Epub 2014 Mar 12. PMID: 24623800; PMCID: PMC3989805. 6: Huang SK, Chiu AW, Pu YS, Huang YK, Chung CJ, Tsai HJ, Yang MH, Chen CJ, Hsueh YM. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma. Urol Int. 2009;82(2):227-34. doi: 10.1159/000200805. Epub 2009 Mar 19. PMID: 19322015.